G

ood morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and refreshing, because the relentless routine of meetings, deadlines, and what-not has, predictably, returned. To cope, yes, we are quaffing cups of stimulation — vanilla macadamia nut is on top, for those tracking the variety — and, as always, we invite you to join us. Remember, no prescription is required. On that note, here are some tidbits to help you get going. Hope you have a smashing, and please keep in touch …

Following a clash with the Greek government over its decision to withdraw a cancer drug from the market, Roche (ROG) has done an about-face and decided to make the drug available to patients for free, according to Euractive. The Greek health minister accused Roche of blackmail after the drug maker moved to withdraw a cancer drug from the market in response to mandatory discounts imposed by the government.

Unlock this article by subscribing to STAT Plus. Try it FREE for 30 days!

SUBSCRIBE TODAY

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy